Search Results
New Inhalable Antibody Shows Promise in Preclinical Stage
COVID nasal vaccines show promise
COVID-19 Nasal Spray Gets FDA Approval for Phase 1 Clinical Trial
CEO of Aridis Pharmaceuticals explains the successful COVID-19 preclinical study done on hamsters
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD
Approach to Monoclonal Antibodies in Ebola & COVID - Stanford Dept Med Grand Rounds - 16 Sept 2020
Panel: Immunotherapies
Coronavirus: Innovative Treatments & Disappointing Tests
Reducing the Cost of Antimicrobial Resistance
Preclinical Models of Immune-Mediated Diseases to Enable Development of Immunomodulatory Therapies
COVID-19 Update: First Oral Nitric Oxide Therapy Cleared by FDA for Testing
Are Intranasal vaccines better than the traditional vaccine shots?
